Is a complete CLDX research report available?

No complete published report is available for Celldex Therapeutics, Inc. (CLDX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Celldex Therapeutics, Inc. (CLDX)

NASDAQ: CLDX · USD

$29.6

-0.56 (-1.9%)· Recorded snapshot

Market cap	2.3B
Revenue (ttm)	158K
Net income (ttm)	-300.5M
EPS (ttm)	-$4.33
Shares out	78.5M
Volume	707,912
Beta	0.90

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 158K
Net income (ttm): -300.5M
EPS (ttm): -$4.33
Market cap: 2.3B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Metric	Value
Amount currency	USD
CIK code	0000744218
Company name	Celldex Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	15117B202
Earnings date	2026-11-09
Earnings time	amc
Employees	198
Employees change	12
Employees growth	6.45%
Enterprise value	$1.6B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2008-03-10
Is primary listing	Yes
Is SPAC	No
ISIN number	US15117B2025
Last 10-K release date	2026-02-25
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2019-02-11
Last stock split type	Reverse
Market cap	$2.3B
Market cap category	Mid-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$29.59
Price currency	USD
Sector	Healthcare
SIC code	2835
Stock price date	2026-10-28
Symbol	CLDX
U.S. state	New Jersey
Website	https://www.celldex.com

Metric

Value

Amount currency

USD

CIK code

0000744218

Company name

Celldex Therapeutics, Inc.

Country

United States

Country code

CUSIP number

15117B202

Earnings date

2026-11-09

Earnings time

amc

Employees

198

Employees change

Employees growth

6.45%

Enterprise value

$1.6B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2008-03-10

Is primary listing

Yes

Is SPAC

ISIN number

US15117B2025

Last 10-K release date

2026-02-25

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

2019-02-11

Last stock split type

Reverse

Market cap

$2.3B

Market cap category

Mid-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$29.59

Price currency

USD

Sector

Healthcare

SIC code

2835

Stock price date

2026-10-28

Symbol

CLDX

U.S. state

New Jersey

Website

https://www.celldex.com

Metric	Value
Earnings yield	-14.65%
EV/Sales	10,146.54x
FCF / EV yield	-15.1%
FCF yield	-10.45%
Forward EV/Sales	606.8x
Forward P/S	876.55x
P/B ratio	3.31x
P/S ratio	14,657.19x
Price / tangible book value	3.37x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-14.65%

EV/Sales

10,146.54x

FCF / EV yield

-15.1%

FCF yield

-10.45%

Forward EV/Sales

606.8x

Forward P/S

876.55x

P/B ratio

3.31x

P/S ratio

14,657.19x

Price / tangible book value

3.37x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Operating margin	-206,220.25%
Pretax margin	-190,220.89%
Profit per employee	$-1.5M
Revenue per employee	$798
ROA	-27.62%
ROA (5Y)	-19.34%
ROCE	-45.19%
ROE	-43.88%
ROE (5Y)	-31.49%
ROIC	-29.56%
SBC / revenue	21,924.68%

Metric

Value

Operating margin

-206,220.25%

Pretax margin

-190,220.89%

Profit per employee

$-1.5M

Revenue per employee

$798

ROA

-27.62%

ROA (5Y)

-19.34%

ROCE

-45.19%

ROE

-43.88%

ROE (5Y)

-31.49%

ROIC

-29.56%

SBC / revenue

21,924.68%

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth	-97.27%
Revenue growth (Q)	-96.99%
Revenue growth (QoQ)	46.67%
Revenue growth 10Y	-29.89%
Revenue growth 3Y	-63.52%
Revenue growth 5Y	-55.06%
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth

-97.27%

Revenue growth (Q)

-96.99%

Revenue growth (QoQ)

46.67%

Revenue growth 10Y

-29.89%

Revenue growth 3Y

-63.52%

Revenue growth 5Y

-55.06%

Revenue growth years

Metric	Value
Capital expenditures	$-6.5M
Depreciation and amortization	$3.4M
EBIT	$-325.8M
EBITDA	$-322.4M
EPS	$-4.33
FCF per share	$-3.08
Financing cash flow	$327.1M
Free cash flow	$-242.1M
Free cash flow minus SBC	$-276.7M
Gross profit	$-278.6M
Investing cash flow	$-67.1M
Net cash flow	$24.4M
Net income	$-300.5M
Operating cash flow minus SBC	$-270.2M
Operating income	$-325.8M
Revenue	$158,000
Stock-based compensation	$34.6M

Metric

Value

Capital expenditures

$-6.5M

Depreciation and amortization

$3.4M

EBIT

$-325.8M

EBITDA

$-322.4M

EPS

$-4.33

FCF per share

$-3.08

Financing cash flow

$327.1M

Free cash flow

$-242.1M

Free cash flow minus SBC

$-276.7M

Gross profit

$-278.6M

Investing cash flow

$-67.1M

Net cash flow

$24.4M

Net income

$-300.5M

Operating cash flow minus SBC

$-270.2M

Operating income

$-325.8M

Revenue

$158,000

Stock-based compensation

$34.6M

Metric	Value
Altman Z-Score	12.97
Book value per share	$9.10
Debt / equity	0.01
Long-term assets	$57.4M
Long-term liabilities	$6.5M
Net cash (debt)	$712.7M
Net cash / market cap	30.77%
Net cash growth	13.61%
Net debt / equity	-1
Piotroski F-Score	1
Property, plant and equipment	$14.8M
Shareholders' equity	$714.6M
Tangible book value	$687.4M
Tangible book value per share	$8.76
Total assets	$782.3M
Total cash	$717.6M
Total debt	$4.9M
Total liabilities	$67.8M
WACC	9.16%

Metric

Value

Altman Z-Score

12.97

Book value per share

$9.10

Debt / equity

0.01

Long-term assets

$57.4M

Long-term liabilities

$6.5M

Net cash (debt)

$712.7M

Net cash / market cap

30.77%

Net cash growth

13.61%

Net debt / equity

-1

Piotroski F-Score

Property, plant and equipment

$14.8M

Shareholders' equity

$714.6M

Tangible book value

$687.4M

Tangible book value per share

$8.76

Total assets

$782.3M

Total cash

$717.6M

Total debt

$4.9M

Total liabilities

$67.8M

WACC

9.16%

Metric	Value
Asset turnover	0
Current assets	$724.9M
Current liabilities	$61.3M
Current ratio	11.82
Net working capital	$-52.4M
Quick ratio	11.71
Working capital	$663.6M
Working capital turnover	0

Metric

Value

Asset turnover

Current assets

$724.9M

Current liabilities

$61.3M

Current ratio

11.82

Net working capital

$-52.4M

Quick ratio

11.71

Working capital

$663.6M

Working capital turnover

Metric	Value
Buyback yield / dilution	-4.49%
Dividend yield	0%
Shareholder yield	-4.49%

Metric

Value

Buyback yield / dilution

-4.49%

Dividend yield

Shareholder yield

-4.49%

Metric	Value
10Y price change	-39.48%
10Y return CAGR	-4.9%
10Y total return	-39.48%
150-day SMA	$34.46
15Y price change	-38.34%
15Y return CAGR	-3.17%
15Y total return	-38.34%
1D price change	-1.86%
1M price change	-5.72%
1M total return	-5.72%
1W price change	-3.2%
1W total return	-3.2%
1Y price change	7.13%
1Y return CAGR	7.13%
1Y total return	7.13%
20-day SMA	$29.78
200-day SMA	$32.61
3M price change	-17.76%
3M total return	-17.76%
3Y price change	29.68%
3Y return CAGR	9.05%
3Y total return	29.68%
50-day SMA	$34.48
50-day SMA vs 200-day SMA	50over200
52-week high	$45.14
52-week high date	2026-08-12
52-week low	$22.10
52-week low date	2025-11-11
5Y price change	-34.19%
5Y return CAGR	-8.03%
5Y total return	-34.19%
6M price change	-12.89%
6M total return	-12.89%
All-time high	$582.60
All-time high date	2013-10-02
All-time low	$1.50
All-time low date	2020-03-19
Average true range (ATR)	$1.44
Average volume	1.3M
Beta (1Y)	1.28
Beta (2Y)	1.42
Beta (5Y)	0.9
Change from 52-week high	-34.45%
Change from 52-week low	33.89%
Change from all-time high	-94.97%
Change from all-time low	1,854.67%
Change from open	0.14%
Day's gap	-1.99%
Dollar volume	$20.9M
High price	$29.59
Low price	$28.96
Monthly RSI	48.5
Open price	$29.55
Position in 52-week range	100%
Premarket change	-0.66%
Premarket close	$30.15
Premarket price	$29.95
Premarket volume	4.2K
Previous close	$30.15
Price vs 150-day SMA	-14.92%
Price vs 20-day SMA	-1.53%
Price vs 200-day SMA	-10.08%
Price vs 50-day SMA	-14.97%
Relative volume	0.53
RSI	41.66
Sharpe ratio	0.31
Sharpe ratio (3Y)	0.32
Sharpe ratio (5Y)	0.05
Sortino ratio	0.61
Sortino ratio (3Y)	0.61
Sortino ratio (5Y)	0.19
Volume	707.9K
Weekly RSI	42.69
YTD price change	7.95%
YTD total return	7.95%

Metric

Value

10Y price change

-39.48%

10Y return CAGR

-4.9%

10Y total return

-39.48%

150-day SMA

$34.46

15Y price change

-38.34%

15Y return CAGR

-3.17%

15Y total return

-38.34%

1D price change

-1.86%

1M price change

-5.72%

1M total return

-5.72%

1W price change

-3.2%

1W total return

-3.2%

1Y price change

7.13%

1Y return CAGR

7.13%

1Y total return

7.13%

20-day SMA

$29.78

200-day SMA

$32.61

3M price change

-17.76%

3M total return

-17.76%

3Y price change

29.68%

3Y return CAGR

9.05%

3Y total return

29.68%

50-day SMA

$34.48

50-day SMA vs 200-day SMA

50over200

52-week high

$45.14

52-week high date

2026-08-12

52-week low

$22.10

52-week low date

2025-11-11

5Y price change

-34.19%

5Y return CAGR

-8.03%

5Y total return

-34.19%

6M price change

-12.89%

6M total return

-12.89%

All-time high

$582.60

All-time high date

2013-10-02

All-time low

$1.50

All-time low date

2020-03-19

Average true range (ATR)

$1.44

Average volume

1.3M

Beta (1Y)

1.28

Beta (2Y)

1.42

Beta (5Y)

0.9

Change from 52-week high

-34.45%

Change from 52-week low

33.89%

Change from all-time high

-94.97%

Change from all-time low

1,854.67%

Change from open

0.14%

Day's gap

-1.99%

Dollar volume

$20.9M

High price

$29.59

Low price

$28.96

Monthly RSI

48.5

Open price

$29.55

Position in 52-week range

100%

Premarket change

-0.66%

Premarket close

$30.15

Premarket price

$29.95

Premarket volume

4.2K

Previous close

$30.15

Price vs 150-day SMA

-14.92%

Price vs 20-day SMA

-1.53%

Price vs 200-day SMA

-10.08%

Price vs 50-day SMA

-14.97%

Relative volume

0.53

RSI

41.66

Sharpe ratio

0.31

Sharpe ratio (3Y)

0.32

Sharpe ratio (5Y)

0.05

Sortino ratio

0.61

Sortino ratio (3Y)

0.61

Sortino ratio (5Y)

0.19

Volume

707.9K

Weekly RSI

42.69

YTD price change

7.95%

YTD total return

7.95%

Metric	Value
Float	73M
Float percentage	92.98%
Shares change (QoQ)	16.94%
Shares change (YoY)	4.49%
Shares held by insiders	0.24%
Shares held by institutions	110.56%
Shares outstanding	78.5M
Short % of float	15.07%
Short % of shares	14.02%
Short ratio	6 days

Metric

Value

Float

73M

Float percentage

92.98%

Shares change (QoQ)

16.94%

Shares change (YoY)

4.49%

Shares held by insiders

0.24%

Shares held by institutions

110.56%

Shares outstanding

78.5M

Short % of float

15.07%

Short % of shares

14.02%

Short ratio

6 days

Celldex Therapeutics, Inc. (CLDX)

Price

Financial snapshot

Fair-value bridge

Latest news · CLDX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CLDX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CLDX

Frequently asked questions